BioCentury
ARTICLE | Clinical News

GW Pharma, Otsuka Pharmaceutical preclinical data

September 24, 2012 7:00 AM UTC

In mice, >=50 mg/kg CBDV significantly reduced maximal electroshock-induced seizures and >=100 mg/kg CBDV significantly reduced audiogenic-induced seizures. In rats, >=100 mg/kg CBDV significantly red...